International Journal of Radiation Oncology*Biology*Physics
Volume 10, Issue 9, September 1984, Pages 1703-1707
Dose-response relationships for human tumors: Implications for clinical trials of dose modifying agents☆
References (39)
- et al.
The dose-time relationship in the radiotherapy of carcinoma of the cervix uteri: an application of the CRE formalism
Clin. Radiol.
(1979) - et al.
Results of radical radiotherapeutic treatment of carcinoma of the pyriform sinus
Int. J. Radiat. Oncol. Biol. Phys.
(1982) - et al.
Initial report of the Phase 1 trial of the hypoxic cell radiosensitizer SR-2508
Int. J. Radial. Oncol. Biol. Phys.
(1984) Dose, time and fractionation: A clinical hypothesis
Clin. Radiol.
(1969)Doses and fractionation schemes to be employed in clinical trials of high-LET radiations
- et al.
A review of hypoxic cell radiosensitization in experimental tumours
Pharmac. Ther.
(1979) - et al.
T3 glottic cancer: An analysis of dose time-volume factors
Int. J. Radiat. Oncol. Biol. Phys.
(1980) - et al.
Supraglottic laryngeal carcinoma: An analysis of dose-timevolume factors in 410 patients
Int. J. Radiat. Oncol. Biol. Phys.
(1983) - et al.
Radiotherapy and hyperbaric oxygen in head and neck cancer
Lancet
(1977) - et al.
The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx
Int. J. Radiat. Oncol. Biol. Phys.
(1983)
Carcinoma of the nasopharynx
Am. J Surg.
(1972)
The results of treatment of cancer of the bladder—a clinical contribution to radiobiology
Clin. Radiol.
(1975)
A re-evaluation of split course technique for squamous cell carcinoma of the head and neck
Int. J. Radiat. Oncol. Biol. Phys
(1980)
Carcinoma of the tonsillar fossa. Significance of dose of irradiation and volume treated in the control of the primary tumor and metastatic neck nodes
Int. J. Radiat. Oncol. Biol. Phys.
(1976)
Dose-response relationship for supraglottic laryngeal carcinoma
Int. J. Radiat. Oncol. Biol. Phys.
(1983)
The problem: Tumor radioresistance in clinical radiotherapy
Int. J. Radiat. Oncol. Biol. Phys.
(1982)
A Phase I study of the hypoxic cell radiosensitizer Ro 038799
Int. J. Radiat. Oncol. Biol. Phys.
(1984)
The clinical testing of Ro 03-8799—Pharmacokinetics, toxicology, tissue and tumor concentrations
Int. J. Radiat. Oncol. Biol. Phys.
(1984)
The different clinical presentation, behaviour and prognosis of carcinomas originating in the epilarynx and the lower supraglottis
Radiother. Oncol.
(1983)
Cited by (32)
Cyto-genotoxicity assessment of potential radioprotector, 3,3'-diselenodipropionic acid (DSePA) in Chinese Hamster Ovary (CHO) cells and human peripheral blood lymphocytes
2014, Mutation Research - Genetic Toxicology and Environmental MutagenesisPortal imaging for evaluation of daily on-line setup errors and off-line organ motion during conformal irradiation of carcinoma of the prostate
2001, International Journal of Radiation Oncology Biology PhysicsThe accuracy of patient positioning in rectum cancer irradiation
1998, Cancer/RadiotherapieNormal tissue radiosensitivity - how important is it?
1996, Clinical OncologyRadiation dose-response of human tumors
1995, International Journal of Radiation Oncology, Biology, Physics
- ☆
Proceedings of Banff Conference on: Chemical modifiers of Cancer Treatment.
Copyright © 1984 Published by Elsevier Inc.